Antiaging Quantum Living Inc. Files 2024 10-K

TL;DR

<b>Antiaging Quantum Living Inc. has filed its annual 10-K report for the fiscal year ending March 31, 2024.</b>

AI Summary

Antiaging Quantum Living Inc. (AAQL) filed a Annual Report (10-K) with the SEC on April 15, 2024. Antiaging Quantum Living Inc. filed its 10-K for the fiscal year ending March 31, 2024. The company was formerly known as Achison Inc. and changed its name on April 19, 2016. The filing includes financial data for the fiscal years ending March 31, 2024, March 31, 2023, and March 31, 2022. Key dates mentioned include stock purchase agreements from June 29, 2019, and April 9, 2023. The company's principal executive offices are located in Flushing, NY.

Why It Matters

For investors and stakeholders tracking Antiaging Quantum Living Inc., this filing contains several important signals. This 10-K filing provides a comprehensive overview of Antiaging Quantum Living Inc.'s financial performance and business operations for the fiscal year 2024, offering insights into its current standing and future outlook. The filing details historical financial data and significant corporate events, including name changes and stock purchase agreements, which are crucial for understanding the company's evolution and strategic decisions.

Risk Assessment

Risk Level: low — Antiaging Quantum Living Inc. shows low risk based on this filing. The filing is a standard 10-K, and no immediate red flags or significant negative indicators are apparent from the header information alone.

Analyst Insight

Review the full 10-K filing to understand the company's financial health, business strategy, and any disclosed risks or opportunities.

Key Numbers

• 2024-03-31 — Fiscal Year End (Reporting period)
• 2024-04-15 — Filing Date (Date of submission)
• 135-22 Northern Blvd, 2nd Fl, Flushing, NY 11354 — Business Address (Company's principal office location)
• 9174705393 — Business Phone (Contact number)
• 2016-04-19 — Name Change Date (Date of former name change to current)

Key Players & Entities

• Antiaging Quantum Living Inc. (company) — Filer name
• Achison Inc (company) — Former company name
• Dazhong368 Inc (company) — Mentioned in relation to a stock purchase agreement
• MR Barry Wan (person) — Mentioned in relation to a stock purchase agreement

FAQ

Industry Context

The company operates within the Services-Direct Mail Advertising Services sector (SIC 7331).

Regulatory Implications

The filing is a 10-K, which is a mandatory annual report required by the Securities and Exchange Commission (SEC) for publicly traded companies.

What Investors Should Do

1. Analyze the detailed financial statements within the 10-K for revenue, net income, and balance sheet figures.
2. Review the Management's Discussion and Analysis (MD&A) section for insights into business performance and future outlook.
3. Examine the Risk Factors section for potential challenges and uncertainties facing the company.

Key Dates

• 2024-03-31: Fiscal Year End — End of the reporting period for the 10-K.
• 2024-04-15: Filing Date — Date the 10-K was officially submitted to the SEC.
• 2016-04-19: Name Change — Date Antiaging Quantum Living Inc. changed from its former name, Achison Inc.
• 2023-04-09: Stock Purchase Agreement — Date related to a stock purchase agreement involving MR Barry Wan.

Year-Over-Year Comparison

This is the initial analysis of the 2024 10-K filing; comparison to prior filings will require access to those documents.

Key Financial Figures

• $5.00 — ty that has a market price of less than $5.00 per share or with an exercise price of
• $0.88 — n stock reported on the OTC Markets was $0.88 per share. The following table sets for
• $7,499 — pany generated revenue in the amount of $7,499 and $13,600, respectively. During the y
• $13,600 — ted revenue in the amount of $7,499 and $13,600, respectively. During the years ended M
• $419,745 — Company incurred operating expenses of $419,745 and $50,230, respectively. The increase
• $50,230 — rred operating expenses of $419,745 and $50,230, respectively. The increase in operatin
• $10,000 — rease in charitable donation expense of $10,000, rental expenses and employee wages and
• $412,971 — ended March 31, 2024, our net loss was $412,971 comparing t

Filing Documents

• form10-k.htm (10-K) — 634KB
• ex31-1.htm (EX-31.1) — 18KB
• ex31-2.htm (EX-31.2) — 18KB
• ex32-1.htm (EX-32.1) — 9KB
• 0001493152-24-014576.txt (&nbsp;) — 3193KB
• achn-20240331.xsd (EX-101.SCH) — 25KB
• achn-20240331_cal.xml (EX-101.CAL) — 47KB
• achn-20240331_def.xml (EX-101.DEF) — 78KB
• achn-20240331_lab.xml (EX-101.LAB) — 212KB
• achn-20240331_pre.xml (EX-101.PRE) — 164KB
• form10-k_htm.xml (XML) — 355KB

Business

Business 3 Item 1A.

Risk Factors

Risk Factors 5 Item 1B. Unresolved Staff Comments 5 Item 2.

Properties

Properties 5 Item 3.

Legal Proceedings

Legal Proceedings 5 Item 4. Mine Safety Disclosures 5 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 6 Item 6.

Selected Financial Data

Selected Financial Data 7 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 7 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 9 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 9 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 10 Item 9A.

Controls and Procedures

Controls and Procedures 10 Item 9B. Other Information 11 PART III Item 10. Directors, Executive Officers and Corporate Governance 11 Item 11.

Executive Compensation

Executive Compensation 13 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 14 Item 13. Certain Relationships and Related Transactions, and Director Independence 15 Item 14. Principal Accounting Fees and Services 15 PART IV Item 15. Exhibits, Financial Statement Schedules 16

Signatures

Signatures 17 2 NOTE ABOUT FORWARD-LOOKING STATEMENTS The information contained in this Report includes some statements that are not purely historical and that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward-looking statements relate to, among other things, expectations of the business environment in which we operate, perceived opportunities in the market and statements regarding our mission and vision. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. You can generally identify forward-looking statements as statements containing the words "anticipates," "believes," "continue," "could," "estimates," "expects," "intends," "may," "might," "plans," "possible," "potential," "predicts," "projects," "seeks," "should," "will," "would" and similar expressions, or the negatives of such terms, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking forward-looking statements. The forward-looking statements contained herein are based on various assumptions, many of which are based, in turn, upon further assumptions. Our expectations, beliefs and forward-looking statements are expressed in good faith on the basis of management's views and assumptions as of the time the statements are made, but there can be no assurance that management's expectations, beliefs or projections will result or be achieved or accomplished. In addition to other factors and matters discussed elsewhere herein, the following are importan

View Full Filing

View this 10-K filing on SEC EDGAR